Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2382118
Max Phase: Preclinical
Molecular Formula: C19H18FNO
Molecular Weight: 295.36
Molecule Type: Small molecule
Associated Items:
ID: ALA2382118
Max Phase: Preclinical
Molecular Formula: C19H18FNO
Molecular Weight: 295.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(/C=C/c1ccc(N2CCCC2)cc1)c1ccc(F)cc1
Standard InChI: InChI=1S/C19H18FNO/c20-17-8-6-16(7-9-17)19(22)12-5-15-3-10-18(11-4-15)21-13-1-2-14-21/h3-12H,1-2,13-14H2/b12-5+
Standard InChI Key: SVNHQWWCFDSCRH-LFYBBSHMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 295.36 | Molecular Weight (Monoisotopic): 295.1372 | AlogP: 4.32 | #Rotatable Bonds: 4 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.87 | CX LogP: 4.55 | CX LogD: 4.55 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.62 | Np Likeness Score: -1.00 |
1. Kim SH, Lee E, Baek KH, Kwon HB, Woo H, Lee ES, Kwon Y, Na Y.. (2013) Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents., 23 (11): [PMID:23608763] [10.1016/j.bmcl.2013.03.106] |
Source(1):